| Monitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study I Fernández-Miranda, L Pedrosa, M Llanos, FF Franco, S Gómez, ... Clinical Cancer Research 29 (1), 209-220, 2023 | 14 | 2023 |
| Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the ATEZOBLADDERPRESERVE phase II trial … S Vazquez-Estevez, O Fernandez-Calvo, T Bonfill-Abella, S Sequero, ... Journal of Clinical Oncology 40 (16_suppl), 4588-4588, 2022 | 5 | 2022 |
| Influence of CYP2D6 polymorphism in the outcome of breast cancer patients undergoing tamoxifen adjuvant treatment. I Blancas, CJ Rodriguez Gonzalez, AJ Munoz-Serrano, MT Delgado, ... Journal of Clinical Oncology 36 (15_suppl), e12521-e12521, 2018 | 3 | 2018 |
| A genetic profiling guideline to support diagnosis and clinical management of lymphomas M Sánchez-Beato, M Méndez, M Guirado, L Pedrosa, S Sequero, ... Clinical and Translational Oncology, 1-20, 2023 | 2 | 2023 |
| SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022) J Gumà, N Palazón-Carrión, A Rueda-Domínguez, S Sequero, V Calvo, ... Clinical and Translational Oncology 25 (9), 2749-2758, 2023 | 2 | 2023 |
| Long‐term follow‐up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group B Núñez‐García, M Rodríguez‐Pertierra, S Sequero, LG Carvajal, ... Hematological Oncology 39 (4), 506-512, 2021 | 2 | 2021 |
| SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry M Gonzalez-Cao, T Puertolas, C Martinez-Vila, C Carrera, ... Clinical and Translational Oncology 25 (3), 768-775, 2023 | 1 | 2023 |
| Evaluation of the conversion rate in Ki-67, estrogen receptor (ER), progesterone receptor (PR) and HER2 between primary breast cancer and relapse and their value as a … IB López-Barajas, A Muñoz, M Legerén, F Galvez, R González, JM Jurado, ... Annals of Oncology 27, vi31, 2016 | 1 | 2016 |
| 1114P Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002-BECARE) A Soria, PS Mauriño, RG Galindo, S Sequero, LG Sanz, G Crespo, ... Annals of Oncology 34, S671-S672, 2023 | | 2023 |
| Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the … M Sánchez-Cánovas, P Jimenez-Fonseca, D Fernández Garay, ... PloS one 18 (5), e0266305, 2023 | | 2023 |
| 837P Real-world evidence of encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma in Spain (GEM 2002-BECARE) A Soria, PS Mauriño, JJ Serrano, S Sequero, JF Rodríguez, V Amezcua, ... Annals of Oncology 33, S932, 2022 | | 2022 |
| Prospective evaluation of the prognostic value of circulating tumor DNA in patients with follicular lymphoma: A pilot study. I Fernández-Miranda, A K Ballesteros, M Llanos, F Franco, ... Journal of Clinical Oncology 40 (16_suppl), 7569-7569, 2022 | | 2022 |
| Prediction of serious complications in patients with cancer and pulmonary thromboembolism: validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO … M Sánchez-Cánovas, P Jimenez-Fonseca, DF Garay, MC Solís, DC Elía, ... medRxiv, 2022.03. 28.22272682, 2022 | | 2022 |
| P53.01 Clinical Application of NGS Technology. Therapeutic Possibilities and Future Perspectives SSLASIGPLGCDCBJ Lopez-Hidalgo Journal of Thoracic oncology, 2021 | | 2021 |
| A GENE SIGNATURE TO PREDICT RISK OF TRANSFORMATION IN PATIENTS WITH FOLLICULAR LYMPHOMA Hematological Oncology 39 (S2), 2021 | | 2021 |
| Can we improve the prediction of the rate of complications following pulmonary embolism diagnosis in cancer patients? Prospective validation of the epiphany INDEX: the PERSEO study M Sanchez Canovas, M Cejuela Solis, E Coma Salvans, D Casado Elia, ... THROMBOSIS RESEARCH 200, S63-S65, 2021 | | 2021 |
| Overcome after Special Use of Bridging Therapy in Refractory DLBCL Subsequently Treated with CAR-T Cell CP Prieto, S Sequero-López Ann Clin Case Rep 6, 1917, 2021 | | 2021 |
| Long-term follow-up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group B Nunez Garcia, M Rodriguez-Pertierra, S Sequero, D Aguiar, ... ANNALS OF ONCOLOGY 31, S650-S650, 2020 | | 2020 |
| 889MO Long-term follow-up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group BN Garcia, M Rodríguez-Pertierra, S Sequero, D Aguiar, LG Carvajal, ... Annals of Oncology 31, S650, 2020 | | 2020 |
| Optimizing management of the oncological patient with pulmonary embolism: Validation of the epiphany index—PERSEO study. M Sanchez Canovas, M Cejuela Solís, I De la Haba Vacas, D Gómez, ... Journal of Clinical Oncology 38 (15_suppl), 12085-12085, 2020 | | 2020 |
Diego Castillo-BarnesPosdoctoral researcher at University of Malaga (Spain)Adresse e-mail validée de ugr.es
